SignalXSignalX

BLFS BIOLIFE SOLUTIONS INC

Q3 2025 10-Q
Filed: Nov 6, 2025Period ending Sep 30, 2025
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR
BIOLIFE SOLUTIONS INC Overview

BIOLIFE SOLUTIONS INC (BLFS) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 6, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q3 2025 10-Q

Risk Factors

  • • New accounting standards ASU 2025-07, ASU 2025-06, ASU 2025-05, ASU 2025-04, ASU 2025-03 issued by FASB, effective 2026-2028, no expected material impact stated
  • • Material update: April 2025 acquisition of PanTHERA, $15.5M in-process R&D cost expensed immediately due to no alternative future use
+3 more insights

Get deeper insights on BIOLIFE SOLUTIONS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.